

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 5.49720957 |
| 2 | regulation of activation of Janus kinase activity (GO:0010533) | 5.36938319 |
| 3 | neutrophil activation (GO:0042119) | 4.07519198 |
| 4 | granulocyte activation (GO:0036230) | 3.98170351 |
| 5 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.93730999 |
| 6 | positive regulation of mast cell activation (GO:0033005) | 3.83935174 |
| 7 | negative regulation of interleukin-12 production (GO:0032695) | 3.71119576 |
| 8 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.67275151 |
| 9 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.64792969 |
| 10 | positive regulation of mast cell degranulation (GO:0043306) | 3.64792969 |
| 11 | T-helper 1 type immune response (GO:0042088) | 3.64369362 |
| 12 | response to peptidoglycan (GO:0032494) | 3.53773028 |
| 13 | immunoglobulin mediated immune response (GO:0016064) | 3.51170647 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 3.39356226 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 3.39356226 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.39356226 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.39356226 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.39356226 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.39356226 |
| 20 | growth hormone receptor signaling pathway (GO:0060396) | 3.36609493 |
| 21 | regulation of mast cell activation (GO:0033003) | 3.28857027 |
| 22 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.25001880 |
| 23 | phagosome maturation (GO:0090382) | 3.18555687 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 3.13481061 |
| 25 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.10472883 |
| 26 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.09862255 |
| 27 | negative regulation of interleukin-1 beta production (GO:0032691) | 3.09181761 |
| 28 | negative regulation of interleukin-1 production (GO:0032692) | 3.08992559 |
| 29 | microglial cell activation (GO:0001774) | 3.08149447 |
| 30 | regulation of mast cell degranulation (GO:0043304) | 3.05700407 |
| 31 | positive regulation of interleukin-17 production (GO:0032740) | 3.04087374 |
| 32 | cellular response to zinc ion (GO:0071294) | 3.03380939 |
| 33 | macrophage activation involved in immune response (GO:0002281) | 3.02936245 |
| 34 | regulation of platelet activation (GO:0010543) | 3.00257350 |
| 35 | negative regulation of interleukin-17 production (GO:0032700) | 2.98718845 |
| 36 | protein neddylation (GO:0045116) | 2.96669490 |
| 37 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 2.93374276 |
| 38 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.91656606 |
| 39 | response to host immune response (GO:0052572) | 2.89924106 |
| 40 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.89924106 |
| 41 | cellular response to growth hormone stimulus (GO:0071378) | 2.89174505 |
| 42 | myeloid cell activation involved in immune response (GO:0002275) | 2.88832331 |
| 43 | regulation of interleukin-17 production (GO:0032660) | 2.82230313 |
| 44 | B cell mediated immunity (GO:0019724) | 2.82017972 |
| 45 | positive regulation of type 2 immune response (GO:0002830) | 2.80013264 |
| 46 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.79700256 |
| 47 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.77283319 |
| 48 | platelet dense granule organization (GO:0060155) | 2.76139145 |
| 49 | regulation of memory T cell differentiation (GO:0043380) | 2.75447052 |
| 50 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.75326031 |
| 51 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.74548912 |
| 52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.73388742 |
| 53 | positive regulation of leukocyte degranulation (GO:0043302) | 2.72358190 |
| 54 | negative regulation of mast cell activation (GO:0033004) | 2.71350693 |
| 55 | cellular response to arsenic-containing substance (GO:0071243) | 2.69582116 |
| 56 | regulation of antigen processing and presentation (GO:0002577) | 2.68569495 |
| 57 | thrombin receptor signaling pathway (GO:0070493) | 2.68294321 |
| 58 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.65996695 |
| 59 | regulation of platelet aggregation (GO:0090330) | 2.64907469 |
| 60 | positive regulation of antigen processing and presentation (GO:0002579) | 2.64176290 |
| 61 | superoxide anion generation (GO:0042554) | 2.64050114 |
| 62 | leukocyte degranulation (GO:0043299) | 2.62334553 |
| 63 | amine catabolic process (GO:0009310) | 2.61953890 |
| 64 | cellular biogenic amine catabolic process (GO:0042402) | 2.61953890 |
| 65 | regulation of mononuclear cell migration (GO:0071675) | 2.61850027 |
| 66 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.61669557 |
| 67 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.61402488 |
| 68 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.60195624 |
| 69 | regulation of vitamin metabolic process (GO:0030656) | 2.57813599 |
| 70 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.57636554 |
| 71 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.56488067 |
| 72 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.56193351 |
| 73 | negative regulation of cell killing (GO:0031342) | 2.56193351 |
| 74 | purine nucleotide salvage (GO:0032261) | 2.56085193 |
| 75 | negative regulation of lipid storage (GO:0010888) | 2.54646169 |
| 76 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.53203377 |
| 77 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.51904968 |
| 78 | lipoxygenase pathway (GO:0019372) | 2.50535815 |
| 79 | regulation of T cell tolerance induction (GO:0002664) | 2.49406518 |
| 80 | cellular extravasation (GO:0045123) | 2.49395223 |
| 81 | regulation of interleukin-12 production (GO:0032655) | 2.47987559 |
| 82 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.46751328 |
| 83 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.46323436 |
| 84 | macrophage activation (GO:0042116) | 2.46056712 |
| 85 | regulation of T-helper 1 type immune response (GO:0002825) | 2.45556740 |
| 86 | regulation of monocyte chemotaxis (GO:0090025) | 2.45325628 |
| 87 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.43556897 |
| 88 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.43425426 |
| 89 | positive regulation of interleukin-10 production (GO:0032733) | 2.43422336 |
| 90 | lymphocyte chemotaxis (GO:0048247) | 2.42557901 |
| 91 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.42324439 |
| 92 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.42324439 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.41324316 |
| 94 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.40637071 |
| 95 | response to host (GO:0075136) | 2.40637071 |
| 96 | response to host defenses (GO:0052200) | 2.40637071 |
| 97 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.40119730 |
| 98 | neutrophil mediated immunity (GO:0002446) | 2.39922046 |
| 99 | defense response to protozoan (GO:0042832) | 2.39866798 |
| 100 | positive regulation of interleukin-12 production (GO:0032735) | 2.39851397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.39059295 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.23868709 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.03313923 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.84838127 |
| 5 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.50783141 |
| 6 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.96372994 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86531088 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.70012012 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.68835797 |
| 10 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.64883067 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.59185168 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.50432784 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.47569052 |
| 14 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.42054746 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.41025901 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.32338988 |
| 17 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.26866679 |
| 18 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.22224958 |
| 19 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.19136043 |
| 20 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.16600549 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.08887838 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.99516576 |
| 23 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96682297 |
| 24 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91254877 |
| 25 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.88825299 |
| 26 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.84578684 |
| 27 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.80966204 |
| 28 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78784601 |
| 29 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.70095213 |
| 30 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63854992 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58576449 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.53860446 |
| 33 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48304863 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.47883240 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45406995 |
| 36 | GATA1_19941826_ChIP-Seq_K562_Human | 1.44032602 |
| 37 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33180145 |
| 38 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32874157 |
| 39 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32575958 |
| 40 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32495072 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32467647 |
| 42 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30677768 |
| 43 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.30395709 |
| 44 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.30077797 |
| 45 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28677739 |
| 46 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26275288 |
| 47 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24951690 |
| 48 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24351034 |
| 49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24189314 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23263344 |
| 51 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22556162 |
| 52 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20522871 |
| 53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.20171156 |
| 54 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19857362 |
| 55 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18518050 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.17059960 |
| 57 | MYB_26560356_Chip-Seq_TH2_Human | 1.15713021 |
| 58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15574685 |
| 59 | GATA2_19941826_ChIP-Seq_K562_Human | 1.15422079 |
| 60 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14766065 |
| 61 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14419344 |
| 62 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.13687739 |
| 63 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.09917861 |
| 64 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08449198 |
| 65 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.08301695 |
| 66 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05847277 |
| 67 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.05815113 |
| 68 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.03869576 |
| 69 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.02478889 |
| 70 | AR_20517297_ChIP-Seq_VCAP_Human | 1.02431818 |
| 71 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.00814968 |
| 72 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97655600 |
| 73 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.97471783 |
| 74 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.96368306 |
| 75 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.95032923 |
| 76 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92614880 |
| 77 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.92603878 |
| 78 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92176642 |
| 79 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.91761846 |
| 80 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.91701060 |
| 81 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.90849844 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.90605257 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90377452 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88788701 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87821406 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86178285 |
| 87 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85904154 |
| 88 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.85023932 |
| 89 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.84408251 |
| 90 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83814727 |
| 91 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.83506152 |
| 92 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.82506769 |
| 93 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81546609 |
| 94 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.80441925 |
| 95 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.80164780 |
| 96 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.79123844 |
| 97 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.77643715 |
| 98 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.77165116 |
| 99 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.77165116 |
| 100 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.76918244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003724_increased_susceptibility_to | 4.28884535 |
| 2 | MP0003303_peritoneal_inflammation | 3.76149234 |
| 3 | MP0005464_abnormal_platelet_physiology | 3.62637347 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.25650478 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.21815812 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.03545505 |
| 7 | MP0009785_altered_susceptibility_to | 2.96594366 |
| 8 | MP0009764_decreased_sensitivity_to | 2.93287085 |
| 9 | MP0005451_abnormal_body_composition | 2.84424432 |
| 10 | MP0005671_abnormal_response_to | 2.70104536 |
| 11 | MP0003436_decreased_susceptibility_to | 2.46529804 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.36294189 |
| 13 | MP0000343_altered_response_to | 2.33072389 |
| 14 | MP0002419_abnormal_innate_immunity | 2.30232847 |
| 15 | MP0008004_abnormal_stomach_pH | 2.15682133 |
| 16 | MP0002723_abnormal_immune_serum | 2.10006662 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.06519047 |
| 18 | MP0005025_abnormal_response_to | 2.05915028 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.05576578 |
| 20 | MP0001800_abnormal_humoral_immune | 2.01219969 |
| 21 | MP0000685_abnormal_immune_system | 1.96423595 |
| 22 | MP0003656_abnormal_erythrocyte_physiolo | 1.81699803 |
| 23 | MP0003075_altered_response_to | 1.81209244 |
| 24 | MP0005387_immune_system_phenotype | 1.80332341 |
| 25 | MP0001790_abnormal_immune_system | 1.80332341 |
| 26 | MP0003195_calcinosis | 1.79231653 |
| 27 | MP0001845_abnormal_inflammatory_respons | 1.74199037 |
| 28 | MP0001819_abnormal_immune_cell | 1.69740969 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.66510728 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.65835191 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.62467478 |
| 32 | MP0003186_abnormal_redox_activity | 1.57347299 |
| 33 | MP0004510_myositis | 1.55205487 |
| 34 | MP0006082_CNS_inflammation | 1.54871246 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.54714473 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.54230138 |
| 37 | MP0009765_abnormal_xenobiotic_induced | 1.49521599 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.47861512 |
| 39 | MP0008469_abnormal_protein_level | 1.47371852 |
| 40 | MP0002139_abnormal_hepatobiliary_system | 1.46699417 |
| 41 | MP0009840_abnormal_foam_cell | 1.44065228 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.42429190 |
| 43 | MP0004947_skin_inflammation | 1.40907896 |
| 44 | MP0000015_abnormal_ear_pigmentation | 1.40825059 |
| 45 | MP0008260_abnormal_autophagy | 1.36642682 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.32878089 |
| 47 | MP0003011_delayed_dark_adaptation | 1.32851276 |
| 48 | MP0009278_abnormal_bone_marrow | 1.27773912 |
| 49 | MP0002405_respiratory_system_inflammati | 1.27526492 |
| 50 | MP0009763_increased_sensitivity_to | 1.21999407 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.20981856 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.20981856 |
| 53 | MP0002837_dystrophic_cardiac_calcinosis | 1.15694322 |
| 54 | MP0003828_pulmonary_edema | 1.15581632 |
| 55 | MP0005410_abnormal_fertilization | 1.13986667 |
| 56 | MP0000858_altered_metastatic_potential | 1.11798136 |
| 57 | MP0005166_decreased_susceptibility_to | 1.08871115 |
| 58 | MP0001663_abnormal_digestive_system | 1.07775370 |
| 59 | MP0000716_abnormal_immune_system | 1.07386244 |
| 60 | MP0003300_gastrointestinal_ulcer | 1.06455774 |
| 61 | MP0000604_amyloidosis | 1.04674379 |
| 62 | MP0002398_abnormal_bone_marrow | 1.03822934 |
| 63 | MP0002095_abnormal_skin_pigmentation | 1.02241680 |
| 64 | MP0005164_abnormal_response_to | 0.99225527 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 0.97936798 |
| 66 | MP0005646_abnormal_pituitary_gland | 0.97236168 |
| 67 | MP0005084_abnormal_gallbladder_morpholo | 0.97118952 |
| 68 | MP0003136_yellow_coat_color | 0.97020203 |
| 69 | MP0003183_abnormal_peptide_metabolism | 0.93041820 |
| 70 | MP0004147_increased_porphyrin_level | 0.92925313 |
| 71 | MP0002429_abnormal_blood_cell | 0.92814394 |
| 72 | MP0002998_abnormal_bone_remodeling | 0.91846594 |
| 73 | MP0003191_abnormal_cellular_cholesterol | 0.90277745 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 0.89586709 |
| 75 | MP0000230_abnormal_systemic_arterial | 0.88108849 |
| 76 | MP0008875_abnormal_xenobiotic_pharmacok | 0.87086569 |
| 77 | MP0003045_fibrosis | 0.86208146 |
| 78 | MP0004381_abnormal_hair_follicle | 0.85284505 |
| 79 | MP0006054_spinal_hemorrhage | 0.84355752 |
| 80 | MP0000689_abnormal_spleen_morphology | 0.84298837 |
| 81 | MP0000371_diluted_coat_color | 0.83466331 |
| 82 | MP0003646_muscle_fatigue | 0.83144917 |
| 83 | MP0003878_abnormal_ear_physiology | 0.83035613 |
| 84 | MP0005377_hearing/vestibular/ear_phenot | 0.83035613 |
| 85 | MP0003448_altered_tumor_morphology | 0.81525072 |
| 86 | MP0008872_abnormal_physiological_respon | 0.81283130 |
| 87 | MP0005075_abnormal_melanosome_morpholog | 0.80663996 |
| 88 | MP0005319_abnormal_enzyme/_coenzyme | 0.76236632 |
| 89 | MP0003638_abnormal_response/metabolism_ | 0.75760052 |
| 90 | MP0002332_abnormal_exercise_endurance | 0.74690784 |
| 91 | MP0003879_abnormal_hair_cell | 0.73086105 |
| 92 | MP0002736_abnormal_nociception_after | 0.71897346 |
| 93 | MP0000249_abnormal_blood_vessel | 0.71646602 |
| 94 | MP0003866_abnormal_defecation | 0.71370445 |
| 95 | MP0004885_abnormal_endolymph | 0.70071363 |
| 96 | MP0006036_abnormal_mitochondrial_physio | 0.69418476 |
| 97 | MP0002722_abnormal_immune_system | 0.69088565 |
| 98 | MP0001542_abnormal_bone_strength | 0.68566779 |
| 99 | MP0002132_abnormal_respiratory_system | 0.67568646 |
| 100 | MP0005083_abnormal_biliary_tract | 0.67541819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Petechiae (HP:0000967) | 4.93666338 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.18385616 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.18385616 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.18385616 |
| 5 | Prolonged bleeding time (HP:0003010) | 4.08557937 |
| 6 | Stomatitis (HP:0010280) | 4.07715727 |
| 7 | Purpura (HP:0000979) | 4.05405142 |
| 8 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.70890937 |
| 9 | Gastrointestinal infarctions (HP:0005244) | 3.59405961 |
| 10 | Epistaxis (HP:0000421) | 3.55567634 |
| 11 | Recurrent abscess formation (HP:0002722) | 3.52930439 |
| 12 | Abnormality of macrophages (HP:0004311) | 3.46990069 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.44723071 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.41413725 |
| 15 | Obstructive lung disease (HP:0006536) | 3.41413725 |
| 16 | Optic neuritis (HP:0100653) | 3.38878455 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.38878455 |
| 18 | Orchitis (HP:0100796) | 3.37473404 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 3.34379087 |
| 20 | Gingival bleeding (HP:0000225) | 3.33857684 |
| 21 | Myositis (HP:0100614) | 3.33443428 |
| 22 | Hemoptysis (HP:0002105) | 3.21376543 |
| 23 | Abnormal hemoglobin (HP:0011902) | 3.16118540 |
| 24 | Increased IgM level (HP:0003496) | 3.10620667 |
| 25 | Decreased central vision (HP:0007663) | 3.00390056 |
| 26 | Vasculitis (HP:0002633) | 3.00225631 |
| 27 | Spontaneous hematomas (HP:0007420) | 2.94330739 |
| 28 | Menorrhagia (HP:0000132) | 2.94280950 |
| 29 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.93373293 |
| 30 | Eczematoid dermatitis (HP:0000976) | 2.88500103 |
| 31 | Anorexia (HP:0002039) | 2.82776294 |
| 32 | Abnormal platelet volume (HP:0011876) | 2.74469956 |
| 33 | Increased mean platelet volume (HP:0011877) | 2.69815189 |
| 34 | Gangrene (HP:0100758) | 2.64241896 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.63818208 |
| 36 | Urticaria (HP:0001025) | 2.62835456 |
| 37 | Generalized aminoaciduria (HP:0002909) | 2.58035954 |
| 38 | Nausea (HP:0002018) | 2.56635321 |
| 39 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.55621664 |
| 40 | 3-Methylglutaconic aciduria (HP:0003535) | 2.52621038 |
| 41 | Dysostosis multiplex (HP:0000943) | 2.51164227 |
| 42 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.46898272 |
| 43 | Constricted visual fields (HP:0001133) | 2.43929438 |
| 44 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.42596107 |
| 45 | Abnormality of alanine metabolism (HP:0010916) | 2.42596107 |
| 46 | Hyperalaninemia (HP:0003348) | 2.42596107 |
| 47 | Increased serum ferritin (HP:0003281) | 2.42133929 |
| 48 | Impaired platelet aggregation (HP:0003540) | 2.39530365 |
| 49 | Abnormal platelet function (HP:0011869) | 2.39530365 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.38603862 |
| 51 | Arterial thrombosis (HP:0004420) | 2.33860374 |
| 52 | Pulmonary embolism (HP:0002204) | 2.32044095 |
| 53 | Episodic fever (HP:0001954) | 2.30878771 |
| 54 | Hyperlipoproteinemia (HP:0010980) | 2.30257320 |
| 55 | Muscle fibrillation (HP:0010546) | 2.26047708 |
| 56 | Vacuolated lymphocytes (HP:0001922) | 2.23802767 |
| 57 | Abnormality of iron homeostasis (HP:0011031) | 2.23168179 |
| 58 | Leukocytosis (HP:0001974) | 2.21951492 |
| 59 | Chest pain (HP:0100749) | 2.19830295 |
| 60 | Tongue fasciculations (HP:0001308) | 2.18714066 |
| 61 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.18321193 |
| 62 | Encephalitis (HP:0002383) | 2.18273098 |
| 63 | Keratoconjunctivitis sicca (HP:0001097) | 2.18011209 |
| 64 | Paralysis (HP:0003470) | 2.15797581 |
| 65 | Albinism (HP:0001022) | 2.15512775 |
| 66 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.15303295 |
| 67 | Microcytic anemia (HP:0001935) | 2.12250364 |
| 68 | Agitation (HP:0000713) | 2.11867770 |
| 69 | Myocardial infarction (HP:0001658) | 2.09081117 |
| 70 | Pustule (HP:0200039) | 2.07636626 |
| 71 | Joint swelling (HP:0001386) | 2.07377094 |
| 72 | Congenital sensorineural hearing impairment (HP:0008527) | 2.02341844 |
| 73 | Peritonitis (HP:0002586) | 2.01580402 |
| 74 | Hepatosplenomegaly (HP:0001433) | 1.98772983 |
| 75 | Acute necrotizing encephalopathy (HP:0006965) | 1.98317844 |
| 76 | Keratoconjunctivitis (HP:0001096) | 1.96823743 |
| 77 | Increased cerebral lipofuscin (HP:0011813) | 1.94929213 |
| 78 | Recurrent fungal infections (HP:0002841) | 1.93740572 |
| 79 | Meningitis (HP:0001287) | 1.93309316 |
| 80 | Glomerulopathy (HP:0100820) | 1.92290685 |
| 81 | Thrombophlebitis (HP:0004418) | 1.90780241 |
| 82 | Congenital stationary night blindness (HP:0007642) | 1.88700453 |
| 83 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88099765 |
| 84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88099765 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88099765 |
| 86 | Abnormality of the prostate (HP:0008775) | 1.86302495 |
| 87 | Recurrent skin infections (HP:0001581) | 1.85782248 |
| 88 | Hypergammaglobulinemia (HP:0010702) | 1.83651909 |
| 89 | Abnormality of the pericardium (HP:0001697) | 1.83153817 |
| 90 | Progressive macrocephaly (HP:0004481) | 1.82946848 |
| 91 | Abnormality of the costochondral junction (HP:0000919) | 1.81728826 |
| 92 | Acute encephalopathy (HP:0006846) | 1.81377203 |
| 93 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.80821950 |
| 94 | Progressive neurologic deterioration (HP:0002344) | 1.80420268 |
| 95 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.77582220 |
| 96 | Amyloidosis (HP:0011034) | 1.77512772 |
| 97 | Systemic lupus erythematosus (HP:0002725) | 1.76583966 |
| 98 | Poikilocytosis (HP:0004447) | 1.76493210 |
| 99 | Cerebral ischemia (HP:0002637) | 1.75802445 |
| 100 | Arthralgia (HP:0002829) | 1.75604172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 3.16375643 |
| 2 | RIPK4 | 3.12850360 |
| 3 | TAOK3 | 2.58260581 |
| 4 | TXK | 2.58221127 |
| 5 | BLK | 2.53566732 |
| 6 | MAP3K11 | 2.48201222 |
| 7 | JAK3 | 2.42415842 |
| 8 | SIK3 | 2.41247343 |
| 9 | MAP3K14 | 2.31040119 |
| 10 | MATK | 2.25884725 |
| 11 | MAP4K1 | 1.98317061 |
| 12 | IKBKB | 1.98019436 |
| 13 | BMPR2 | 1.97875741 |
| 14 | IRAK4 | 1.94409916 |
| 15 | CDK19 | 1.93054392 |
| 16 | TLK1 | 1.92619180 |
| 17 | MAP3K3 | 1.89183761 |
| 18 | FGR | 1.81595968 |
| 19 | GRK6 | 1.79199398 |
| 20 | SYK | 1.73534515 |
| 21 | GRK7 | 1.66381533 |
| 22 | ADRBK2 | 1.58271861 |
| 23 | PIM2 | 1.58173198 |
| 24 | IKBKE | 1.52924954 |
| 25 | MARK3 | 1.46811058 |
| 26 | CSF1R | 1.42701905 |
| 27 | CSK | 1.40544081 |
| 28 | FES | 1.36133325 |
| 29 | TBK1 | 1.33164077 |
| 30 | KIT | 1.29448989 |
| 31 | NME2 | 1.28635797 |
| 32 | ACVR1B | 1.25613659 |
| 33 | TAOK1 | 1.24184632 |
| 34 | MAP4K2 | 1.23774090 |
| 35 | EPHA3 | 1.21798927 |
| 36 | BTK | 1.20546192 |
| 37 | SIK2 | 1.17362452 |
| 38 | LYN | 1.14517059 |
| 39 | MAP2K3 | 1.11879305 |
| 40 | ZAP70 | 1.11550966 |
| 41 | EIF2AK1 | 1.11333548 |
| 42 | MST4 | 1.10176714 |
| 43 | PTK2B | 1.10020940 |
| 44 | TAOK2 | 1.09849625 |
| 45 | IRAK1 | 1.09602217 |
| 46 | EPHB2 | 1.07201497 |
| 47 | TEC | 1.07076374 |
| 48 | BCKDK | 1.04181263 |
| 49 | HCK | 1.04103011 |
| 50 | ABL2 | 0.99618976 |
| 51 | TYK2 | 0.98816320 |
| 52 | MYLK | 0.93640196 |
| 53 | DDR2 | 0.93434438 |
| 54 | MAP3K12 | 0.92618930 |
| 55 | TGFBR2 | 0.83701916 |
| 56 | PIK3CG | 0.82890901 |
| 57 | MAPKAPK3 | 0.81727502 |
| 58 | CAMKK2 | 0.80731769 |
| 59 | MAP3K1 | 0.79480059 |
| 60 | GRK1 | 0.79324960 |
| 61 | JAK2 | 0.78407374 |
| 62 | DAPK2 | 0.77436814 |
| 63 | MAP3K13 | 0.75729536 |
| 64 | TESK2 | 0.75723916 |
| 65 | PINK1 | 0.74225912 |
| 66 | ERN1 | 0.71999188 |
| 67 | MAP3K5 | 0.70743399 |
| 68 | CHUK | 0.69606334 |
| 69 | EPHB1 | 0.67021435 |
| 70 | GRK5 | 0.66378921 |
| 71 | PIM1 | 0.66266150 |
| 72 | LCK | 0.65565194 |
| 73 | PRKCD | 0.61834972 |
| 74 | BMX | 0.60610488 |
| 75 | OXSR1 | 0.60431664 |
| 76 | TRIM28 | 0.59680183 |
| 77 | IRAK2 | 0.59130887 |
| 78 | KDR | 0.58473632 |
| 79 | ADRBK1 | 0.54015701 |
| 80 | TNK2 | 0.53466901 |
| 81 | PLK2 | 0.53446692 |
| 82 | ITK | 0.53041731 |
| 83 | ARAF | 0.51315068 |
| 84 | PRKG2 | 0.50246788 |
| 85 | DYRK3 | 0.50108472 |
| 86 | FER | 0.49772325 |
| 87 | NUAK1 | 0.49205447 |
| 88 | PDK2 | 0.45485102 |
| 89 | SIK1 | 0.42819997 |
| 90 | PRKCQ | 0.41779054 |
| 91 | WNK4 | 0.41732183 |
| 92 | RPS6KA5 | 0.41687459 |
| 93 | DYRK1B | 0.40821183 |
| 94 | CSNK1G3 | 0.40279109 |
| 95 | ABL1 | 0.38978543 |
| 96 | TIE1 | 0.38938510 |
| 97 | PRKD2 | 0.38012306 |
| 98 | STK16 | 0.36941497 |
| 99 | PAK1 | 0.36598161 |
| 100 | IGF1R | 0.36538653 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Asthma_Homo sapiens_hsa05310 | 3.30232027 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.28280794 |
| 3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 3.20849634 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.10160251 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.92552848 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.82297115 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.75750449 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.75703270 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.69627157 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54424731 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.38099648 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.04203114 |
| 13 | Phagosome_Homo sapiens_hsa04145 | 2.00672005 |
| 14 | Tuberculosis_Homo sapiens_hsa05152 | 1.87675091 |
| 15 | Malaria_Homo sapiens_hsa05144 | 1.85170209 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.80139097 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.80056610 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77226617 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77028553 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.76809983 |
| 21 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.65202731 |
| 22 | Lysosome_Homo sapiens_hsa04142 | 1.53300224 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.50922097 |
| 24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.49526291 |
| 25 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.48439663 |
| 26 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.48232740 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.46183200 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42277423 |
| 29 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.41549680 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.39333750 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36535842 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.35655598 |
| 33 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.28396602 |
| 34 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25537402 |
| 35 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.18142214 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14086527 |
| 37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.12526940 |
| 38 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11154910 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11036895 |
| 40 | Platelet activation_Homo sapiens_hsa04611 | 1.10620319 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 1.06967032 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.05761777 |
| 43 | Pertussis_Homo sapiens_hsa05133 | 1.02665403 |
| 44 | Shigellosis_Homo sapiens_hsa05131 | 1.02540515 |
| 45 | Other glycan degradation_Homo sapiens_hsa00511 | 1.02520229 |
| 46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00988147 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95852453 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 0.95820222 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94707061 |
| 50 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93856729 |
| 51 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.84895607 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82597257 |
| 53 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.79873882 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79451930 |
| 55 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75859101 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73582743 |
| 57 | Parkinsons disease_Homo sapiens_hsa05012 | 0.72322306 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71581382 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71292562 |
| 60 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69889769 |
| 61 | Measles_Homo sapiens_hsa05162 | 0.69519323 |
| 62 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.67355788 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.65760438 |
| 64 | Proteasome_Homo sapiens_hsa03050 | 0.57897619 |
| 65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57021923 |
| 66 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56993078 |
| 67 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.53780463 |
| 68 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52621709 |
| 69 | Morphine addiction_Homo sapiens_hsa05032 | 0.46782447 |
| 70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43221622 |
| 71 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.42587335 |
| 72 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.42569996 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41423005 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.40301922 |
| 75 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.40238916 |
| 76 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.39114628 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37867563 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37470494 |
| 79 | Peroxisome_Homo sapiens_hsa04146 | 0.36127496 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.36063961 |
| 81 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.36059382 |
| 82 | Endocytosis_Homo sapiens_hsa04144 | 0.35867621 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.35865255 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.35364825 |
| 85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34380424 |
| 86 | Hepatitis C_Homo sapiens_hsa05160 | 0.34370196 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.33505275 |
| 88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31537021 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.31269841 |
| 90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.30980852 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.30792870 |
| 92 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.30501815 |
| 93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28941527 |
| 94 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.28639890 |
| 95 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28625529 |
| 96 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.27551337 |
| 97 | GABAergic synapse_Homo sapiens_hsa04727 | 0.26384853 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26155071 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.24597642 |
| 100 | Phototransduction_Homo sapiens_hsa04744 | 0.23847546 |

